LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Fedratinib | 0.12 | uM | LJP5 | 1 | L05 | 72 | hr | 1694 | 10900 | 11042 | 0.9871 | 0.9904 |
MCF 10A | Fedratinib | 0.12 | uM | LJP5 | 2 | L05 | 72 | hr | 1694 | 10242 | 11099 | 0.9227 | 0.9416 |
MCF 10A | Fedratinib | 0.12 | uM | LJP5 | 3 | L05 | 72 | hr | 1694 | 10880 | 11168 | 0.9742 | 0.9809 |
MCF 10A | Fedratinib | 0.37 | uM | LJP5 | 1 | L04 | 72 | hr | 1694 | 10418 | 11042 | 0.9435 | 0.9574 |
MCF 10A | Fedratinib | 0.37 | uM | LJP5 | 2 | L04 | 72 | hr | 1694 | 10070 | 11099 | 0.9073 | 0.9295 |
MCF 10A | Fedratinib | 0.37 | uM | LJP5 | 3 | L04 | 72 | hr | 1694 | 10576 | 11168 | 0.9470 | 0.9603 |
MCF 10A | Fedratinib | 1.11 | uM | LJP5 | 1 | L03 | 72 | hr | 1694 | 10131 | 11042 | 0.9175 | 0.9373 |
MCF 10A | Fedratinib | 1.11 | uM | LJP5 | 2 | L03 | 72 | hr | 1694 | 9587 | 11099 | 0.8637 | 0.8948 |
MCF 10A | Fedratinib | 1.11 | uM | LJP5 | 3 | L03 | 72 | hr | 1694 | 10019 | 11168 | 0.8971 | 0.9217 |
MCF 10A | Fedratinib | 3.33 | uM | LJP5 | 1 | L02 | 72 | hr | 1694 | 6996 | 11042 | 0.6336 | 0.6894 |
MCF 10A | Fedratinib | 3.33 | uM | LJP5 | 2 | L02 | 72 | hr | 1694 | 6663 | 11099 | 0.6003 | 0.6569 |
MCF 10A | Fedratinib | 3.33 | uM | LJP5 | 3 | L02 | 72 | hr | 1694 | 7413 | 11168 | 0.6638 | 0.7203 |
MCF 10A | Fedratinib | 10 | uM | LJP5 | 1 | L01 | 72 | hr | 1694 | 1891 | 11042 | 0.1713 | 0.0415 |
MCF 10A | Fedratinib | 10 | uM | LJP5 | 2 | L01 | 72 | hr | 1694 | 2363 | 11099 | 0.2129 | 0.1305 |
MCF 10A | Fedratinib | 10 | uM | LJP5 | 3 | L01 | 72 | hr | 1694 | 2195 | 11168 | 0.1965 | 0.0999 |
MCF 10A | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 1694 | 2800 | 11042 | 0.2536 | 0.2041 |
MCF 10A | Trametinib | 0.04 | uM | LJP5 | 2 | P24 | 72 | hr | 1694 | 2568 | 11099 | 0.2314 | 0.1658 |
MCF 10A | Trametinib | 0.04 | uM | LJP5 | 3 | P24 | 72 | hr | 1694 | 2900 | 11168 | 0.2597 | 0.2184 |
MCF 10A | Trametinib | 0.12 | uM | LJP5 | 1 | P23 | 72 | hr | 1694 | 3024 | 11042 | 0.2739 | 0.2389 |
MCF 10A | Trametinib | 0.12 | uM | LJP5 | 2 | P23 | 72 | hr | 1694 | 3135 | 11099 | 0.2825 | 0.2547 |
MCF 10A | Trametinib | 0.12 | uM | LJP5 | 3 | P23 | 72 | hr | 1694 | 2792 | 11168 | 0.2500 | 0.2015 |
MCF 10A | Trametinib | 0.37 | uM | LJP5 | 1 | P22 | 72 | hr | 1694 | 3106 | 11042 | 0.2813 | 0.2512 |
MCF 10A | Trametinib | 0.37 | uM | LJP5 | 2 | P22 | 72 | hr | 1694 | 3240 | 11099 | 0.2919 | 0.2701 |
MCF 10A | Trametinib | 0.37 | uM | LJP5 | 3 | P22 | 72 | hr | 1694 | 2788 | 11168 | 0.2496 | 0.2009 |
MCF 10A | Trametinib | 1.11 | uM | LJP5 | 1 | P21 | 72 | hr | 1694 | 3333 | 11042 | 0.3018 | 0.2843 |